Literature DB >> 19181302

An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.

Gianluca Martone1, Paolo Frezzotti, Gian Marco Tosi, Claudio Traversi, Vincenzo Mittica, Alex Malandrini, Patrizia Pichierri, Angelo Balestrazzi, Paolo Alfonso Motolese, Ilaria Motolese, Edoardo Motolese.   

Abstract

PURPOSE: To evaluate the long-term effects of preservative-free and preservative-containing antiglaucoma eye drops on the tear secretion and ocular surface.
DESIGN: Comparative retrospective study.
METHODS: A total of 84 patients with bilateral primary open-angle glaucoma or ocular hypertension divided into 5 groups according to type of topical hypotensive therapy and 20 healthy age-matched volunteers were studied. Clinical tests (corneal sensitivity, Schirmer I test, and lachrymal film break-up time), and in vivo confocal microscopy were performed in all patients.
RESULTS: A significant reduction of the scores was found between groups on topical hypotensive therapy and the control group in all clinical parameters studied (P < .05). In particular, the clinical scores were significantly lower in the preservative medication groups than in the preservative-free group (P < .05). The density of superficial epithelial cells was reduced in all glaucomatous patients, except for the preservative-free group (P > .05), with respect to control subjects (P < .001). On the contrary, the density of basal epithelial cells of glaucomatous preservative therapy groups was higher than control and preservative-free groups (P < .05). Stromal keratocyte activation and the number of beads were higher in all glaucoma preservative groups (P < .05). The number of sub-basal nerves was lower in all glaucoma groups than in the control group (P < .05) and tortuosity was significantly higher in glaucoma than control groups (P < .05). Reflectivity of fibers did not show any significant difference between the 6 groups (P < .05).
CONCLUSIONS: Glaucomatous patients with chronic treatment show ocular surface alterations. The development of nontoxic antiglaucoma treatment may reduce damage to the ocular surface and improve the compliance and the adherence in the medical therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181302     DOI: 10.1016/j.ajo.2008.10.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  57 in total

Review 1.  In Vivo Confocal Microscopy of the Cornea: New Developments in Image Acquisition, Reconstruction, and Analysis Using the HRT-Rostock Corneal Module.

Authors:  W Matthew Petroll; Danielle M Robertson
Journal:  Ocul Surf       Date:  2015-05-18       Impact factor: 5.033

2.  Ocular surface evaluation in eyes with chronic glaucoma on long term topical antiglaucoma therapy.

Authors:  Manu Saini; Murugesan Vanathi; Tanuj Dada; Tushar Agarwal; Rebika Dhiman; Sudarshan Khokhar
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

3.  Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.

Authors:  Jack Stringham; Noy Ashkenazy; Anat Galor; Sarah R Wellik
Journal:  Eye Contact Lens       Date:  2018-01       Impact factor: 2.018

4.  Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.

Authors:  M Saini; R Dhiman; T Dada; R Tandon; M Vanathi
Journal:  Eye (Lond)       Date:  2015-04-10       Impact factor: 3.775

Review 5.  Corneal epithelial cells function as surrogate Schwann cells for their sensory nerves.

Authors:  Mary Ann Stepp; Gauri Tadvalkar; Raymond Hakh; Sonali Pal-Ghosh
Journal:  Glia       Date:  2016-11-23       Impact factor: 7.452

6.  Apoptosis in the iris and trabecular meshwork of medically treated and untreated primary open angle glaucoma patients.

Authors:  Zeynep Aktas; Emine Esra Karaca; Ipek Işik Gonul; Murat Hasanreisoglu; Merih Onol
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

Review 7.  In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease.

Authors:  Andrea Cruzat; Yureeda Qazi; Pedram Hamrah
Journal:  Ocul Surf       Date:  2016-10-19       Impact factor: 5.033

Review 8.  In vivo confocal microscopy of the ocular surface: from bench to bedside.

Authors:  Edoardo Villani; Christophe Baudouin; Nathan Efron; Pedram Hamrah; Takashi Kojima; Sanjay V Patel; Stephen C Pflugfelder; Andrey Zhivov; Murat Dogru
Journal:  Curr Eye Res       Date:  2013-11-11       Impact factor: 2.424

9.  Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.

Authors:  Gregory Katz; Clark L Springs; E Randy Craven; Michela Montecchi-Palmer
Journal:  Clin Ophthalmol       Date:  2010-11-03

10.  Evaluation of ocular surface disease in patients with glaucoma.

Authors:  Priya M Mathews; Pradeep Y Ramulu; David S Friedman; Canan A Utine; Esen K Akpek
Journal:  Ophthalmology       Date:  2013-05-25       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.